We performed a comprehensive study of deletions and mutations of the TP53 gene and of telomere parameters, including assessment of telomeres as well as hTERT and shelterin gene expression in 115 CLL patients. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.